Publications by authors named "Danielle Degenne"

Claim this Profile
T
Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule.
Philippe Gatault, Guillaume Brachet, David Ternant, Danielle Degenne, Guillaume Récipon

MAbs· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enzyme-linked immunosorbent assay to study bevacizumab pharmacokinetics.
David Ternant, Nicolas Cézé, Thierry Lecomte, Danielle Degenne, Anne-Claire Duveau

Ther Drug Monit· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.
Konstantinos Karmiris, Gilles Paintaud, Maja Noman, Charlotte Magdelaine-Beuzelin, Marc Ferrante, Danielle Degenne

Gastroenterology· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab.
Nicolas Cézé, David Ternant, Friedrich Piller, Danielle Degenne, Nicolas Azzopardi

Ther Drug Monit· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab.
Charlotte Magdelaine-Beuzelin, Séverine Vermeire, Margaret Goodall, Filip Baert, Maja Noman, Danielle Degenne

Pharmacogenet Genomics· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab pharmacokinetics in inflammatory bowel disease patients.
David Ternant, Alexandre Aubourg, Charlotte Magdelaine-Beuzelin, Danielle Degenne, Hervé Watier

Ther Drug Monit· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of bevacizumab in haemodialysis.
Nathalie Garnier-Viougeat, Olivier Rixe, Gilles Paintaud, David Ternant, Danielle Degenne

Nephrol Dial Transplant· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab.
David Ternant, Denis Mulleman, Danielle Degenne, Stéphanie Willot, Jean-Maurice Guillaumin

Ther Drug Monit· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between occupational risk factors and severity markers of systemic sclerosis.
Julie Magnant, Michèle de Monte, Jean-Louis Guilmot, Gérard Lasfargues, Patrice Diot, Danielle Degenne

J Rheumatol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis